SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-24-001091
Filing Date
2024-07-12
Accepted
2024-07-12 13:26:59
Documents
68
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lxrp_10q.htm   iXBRL 10-Q 1034901
2 FORM OF TAIL WARRANT lxrp_ex42.htm EX-4.2 100420
3 CERTIFICATION lxrp_ex311.htm EX-31.1 11488
4 CERTIFICATION lxrp_ex312.htm EX-31.2 12024
5 CERTIFICATION lxrp_ex321.htm EX-32.1 6216
6 CERTIFICATION lxrp_ex322.htm EX-32.2 6098
  Complete submission text file 0001640334-24-001091.txt   5226790

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20240531.xsd EX-101.SCH 52755
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20240531_lab.xml EX-101.LAB 291944
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20240531_cal.xml EX-101.CAL 44994
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20240531_pre.xml EX-101.PRE 244002
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20240531_def.xml EX-101.DEF 123962
71 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_10q_htm.xml XML 838882
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 241113939
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)